← Open Payments lookup

REIKO TAPIA: Open Payments

NPI 1972211050 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,540 in 186 payments from 19 companies in 2025. Trend: 2023 $1,513 · 2024 $3,994 · 2025 $4,540

Food & beverage: $4,456Education: $84
CompanyPaymentsAmount
ABBVIE INC.29$872
Janssen Biotech, Inc.26$703
Intra-Sana Laboratories39$508
Gilead Sciences, Inc.19$501
Phathom Pharmaceuticals, Inc.11$365
Madrigal Pharmaceuticals8$363
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$281
GENZYME CORPORATION15$190
Aimmune Therapeutics, Inc.4$182
Novo Nordisk Inc5$171

Products named: TREMFYA, RELTONE 200 MG, VOQUEZNA, REZDIFFRA, SKYRIZI, XIFAXAN, RINVOQ, DUPIXENT.

Industry payments across NV — which companies pay providers there.